Wolverine Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,000
Closed -$2.51M 1719
2026
Q1
$2.51M Sell
40,000
-3,800
-9% -$265K 0.02% 508
2025
Q4
$2.91M Hold
43,800
0.02% 483
2025
Q3
$2.95M Buy
43,800
+40,000
+1,053% +$3.17M 0.02% 471
2025
Q2
$332K Hold
3,800
﹤0.01% 953
2025
Q1
$260K Hold
3,800
﹤0.01% 977
2024
Q4
$296K Hold
3,800
﹤0.01% 958
2024
Q3
$255K Buy
+3,800
New +$312K ﹤0.01% 990
2021
Q1
Sell
-160,000
Closed -$14.8M 2075
2020
Q4
$14.8M Hold
160,000
0.11% 153
2020
Q3
$16.5M Hold
160,000
0.15% 120
2020
Q2
$16.2M Buy
+160,000
New +$14.3M 0.16% 126

Other funds holding DXCM

Wolverine Asset Management's DXCM Position: Q2 2026 in Review

Wolverine Asset Management opened a new position in DexCom (DXCM) in Q2 2026: 6,259 shares worth $422K. The stake represents ﹤0.01% of the portfolio and ranks #980 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in DXCM as recently as Q2 2025.

Wolverine Asset Management first reported a position in DXCM in Q2 2017 and has held it in 7 quarters since. The position peaked at $1.6M in Q4 2018. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Wolverine Asset Management held 6,259 shares of DexCom worth $422K as of Q2 2026.
  • DexCom was a new Wolverine Asset Management position in Q2 2026.
  • DexCom made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #980 holding.
  • Wolverine Asset Management first reported a position in DexCom in Q2 2017 and has held it in 7 quarters since.
  • Wolverine Asset Management's DexCom position peaked at $1.6M in Q4 2018.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.